Two Sigma Investments, LP Geron Corp Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.1 - $5.09 $1.25 Million - $2.06 Million	404,621 New	404,621 $1.72 Million
Q4 2023 Feb 14, 2024	BUY	$1.74 - $2.31 $443,733 - $589,093	255,019 New	255,019 $538,000
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $206,531 - $328,134	96,510 Added 797.6%	108,610 $235,000
Q4 2022 Feb 14, 2023	SELL	$2.03 - $2.42 $1.16 Million - $1.39 Million	-573,627 Reduced 97.93%	12,100 $29,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $978,164 - $1.72 Million	585,727 New	585,727 $1.37 Million
Q2 2021 Aug 16, 2021	SELL	$1.25 - $1.83 $2.43 Million - $3.55 Million	-1,941,465 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.52 - $2.1 $543,848 - $751,369	357,795 Added 22.59%	1,941,465 $3.07 Million
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.05 $474,137 - $627,084	305,895 Added 23.94%	1,583,670 $2.52 Million
Q3 2020 Nov 16, 2020	SELL	$1.59 - $2.19 $291,798 - $401,910	-183,521 Reduced 12.56%	1,277,775 $2.22 Million
Q2 2020 Aug 14, 2020	SELL	$1.05 - $2.18 $139,794 - $290,240	-133,138 Reduced 8.35%	1,461,296 $3.19 Million
Q1 2020 May 15, 2020	BUY	$0.89 - $1.49 $604,641 - $1.01 Million	679,373 Added 74.24%	1,594,434 $1.9 Million
Q4 2019 Feb 14, 2020	BUY	$1.27 - $1.54 $488,115 - $591,888	384,343 Added 72.42%	915,061 $1.24 Million
Q3 2019 Nov 14, 2019	BUY	$1.15 - $1.59 $337,286 - $466,335	293,293 Added 123.53%	530,718 $706,000
Q2 2019 Aug 14, 2019	SELL	$1.37 - $2.02 $83,597 - $123,260	-61,020 Reduced 20.45%	237,425 $335,000
Q1 2019 May 15, 2019	SELL	$1.01 - $1.83 $692,950 - $1.26 Million	-686,090 Reduced 69.69%	298,445 $495,000
Q4 2018 Feb 14, 2019	BUY	$0.98 - $1.85 $964,844 - $1.82 Million	984,535 New	984,535 $985,000

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.34B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account